Cargando…
Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Genome-directed therapy is less toxic, prolongs survival and provides a better quality of life. Predictive biomarker testing, therefore, has become a standard of care in advanced lung cancers. The objective of this s...
Autores principales: | Mehta, Anurag, Sriramanakoppa, Nayana N., Agarwal, Poojan, Viswakarma, Gayatri, Vasudevan, Smreti, Panigrahi, Manoj, Kumar, Dushyant, Saifi, Mumtaz, Chowdhary, Irfan, Doval, D. C., Suryavanshi, Moushumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852638/ https://www.ncbi.nlm.nih.gov/pubmed/31807491 http://dx.doi.org/10.4103/sajc.sajc_373_18 |
Ejemplares similares
-
The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2018) -
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
por: Mehta, Anurag, et al.
Publicado: (2018) -
ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017) -
Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2019) -
Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
por: Mehta, Anurag, et al.
Publicado: (2019)